ArticleFrontiers in endocrinology2025
Worldwide impact of disease attributable to low physical activity for diabetes and kidney diseases.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Trends in type 2 diabetes-related deaths and disability-adjusted life years among smoking middle-aged and elderly adults in China, 1990-2021.Tobacco induced diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We aimed to examine patterns of diabetes and kidney disease due to Low physical activity (LPA) in 204 countries between 1990 and 2021. Methods: Data were from the Global Burden of Disease (GBD) 2021. Age-standardized death rate (ASDR) and age standardized disability-adjusted life years (DALYs) were estimated. In addition, annual percentage changes (EAPC) were calculated. Results: The age-standardized DALY rate (EAPC = 0.89; 95% CI: 0.85, 0.93) and age-standardized death rate (ASDR) of diabetes and kidney disease due to LPA increased (EAPC = 0.34; 95% CI: 0.28,0.39) during 1990 to 2021. Among them, the age-standardized DALY rate and ASDR increased fastest in Eastern Europe (EAPC 2.43 and 3.79, respectively). Mauritius had the most significant increase in age-standardized DALY (EAPC = 3.40), while the Russian Federation had the most significant increase in ASDR (EAPC = 4.40). In 2021, both ASDR and age-standardized DALY rates per 100,000 people increased in women compared with men. The age-standardized DALY rate per 100,000 people generally showed an upward trend, with the highest in Oceania (285.33) and the highest ASDR in Southern Sub-Saharan Africa (10.56). Conclusions: The global ASDR and age-standardized DALY rates reveal a significant surge in diabetes and kidney disease attributable to LPA from 1990 to 2021. This escalation is evident across 21 regions, with notable increases observed in Eastern Europe, Sub-Saharan Africa, and Oceania.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.